Effectiveness of 1-year treatment with long-acting formulation of aripiprazole, haloperidol, or paliperidone in patients with schizophrenia: retrospective study in a real-world clinical setting

Rosaria Di Lorenzo,1 Paola Ferri,2 Michela Cameli,3 Sergio Rovesti,4 Chiara Piemonte5 1Psychiatric Intensive Treatment Facility, Department of Mental Health and Drug Abuse, AUSL Modena, Modena, Italy; 2Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia,...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Di Lorenzo R, Ferri P, Cameli M, Rovesti S, Piemonte C
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2019
Materias:	Paliperidone Palmitate once-monthly Haloperidol decanoate Aripiprazole prolonged release once-monthly Schizophrenia relapses and clinical course Long-acting treatment effectiveness. First generation antipsychotics Second generation antipsychotics Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/f989c6af8c7f4cfc85e9bc8165ab097f
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Sea el primero en dejar un comentario!

Effectiveness of 1-year treatment with long-acting formulation of aripiprazole, haloperidol, or paliperidone in patients with schizophrenia: retrospective study in a real-world clinical setting

Ejemplares similares